RARRES3 Antikörper (AA 69-134)
Kurzübersicht für RARRES3 Antikörper (AA 69-134) (ABIN1886616)
Target
Alle RARRES3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 69-134
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Synthetic peptide contain a sequence corresponding to a region within amino acids 69 and 134 of Human RARRES3
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- RARRES3 (Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))
-
Andere Bezeichnung
- RARRES3
-
Hintergrund
-
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases.These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators.RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene.RARRES3 is thought act as a tumor suppressor or growth regulator.[provided by RefSeq]
-
Molekulargewicht
- 18 kDa
-
Gen-ID
- 5920
-
NCBI Accession
- NP_004576, NM_004585
Target
-